Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study
Tiede, Andreas, Hart, Christina, Knöbl, Paul
, Greil, Richard, Oldenburg, Johannes, Sachs, Ulrich J, Miesbach, Wolfgang, Pfrepper, Christian, Trautmann-Grill, Karolin, Holstein, Katharina, Pilch, Jan, Möhnle, Patrick, Schindler, Christoph, Weigt, Carmen, Schipp, Dorothea, May, Marcus
, Dobbelstein, Christiane, Pelzer, Fabius J, Werwitzke, Sonja and Klamroth, Robert
(2023)
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study.
The Lancet Haematology 10 (11), e913-e921.
Date of publication of this fulltext: 18 Mar 2025 10:10
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | The Lancet Haematology | ||||
| Publisher: | ELSEVIER SCI LTD | ||||
|---|---|---|---|---|---|
| Place of Publication: | OXFORD | ||||
| Volume: | 10 | ||||
| Number of Issue or Book Chapter: | 11 | ||||
| Page Range: | e913-e921 | ||||
| Date | 2023 | ||||
| Institutions | Medicine > Abteilung für Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation | ||||
| Identification Number |
| ||||
| Keywords | SURVEILLANCE; MANAGEMENT; INHIBITORS; THERAPY; | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 76163 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric